Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice (Q38478550)

3 September 2017

Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice (English)

1 reference

3 September 2017

Curcuma longa

1 reference

Jungsun Kim

1

1 reference

3 September 2017

Hye-Lin Ha

2

1 reference

3 September 2017

Hyung-Bae Moon

3

1 reference

3 September 2017

Yeon-Weol Lee

4

1 reference

3 September 2017

Chong-Kwan Cho

5

1 reference

3 September 2017

Hwa-Seung Yoo

6

1 reference

3 September 2017

Dae-Yeul Yu

7

1 reference

3 September 2017

29 December 2010

1 reference

Integrative Cancer Therapies

3 September 2017

1 reference

3 September 2017

10

1 reference

3 September 2017

2

1 reference

3 September 2017

168-177

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

3 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Epidemiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Hepatitis B virus genetic variability and evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Mechanism of antiinflammatory actions of curcumine and boswellic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Potential anticancer activity of turmeric (Curcuma longa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Prevention of liver cirrhosis in rats by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Steatosis: co-factor in other liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Proliferating cell nuclear antigen is required for DNA excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Nuclear dynamics of PCNA in DNA replication and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Transcriptional repression of the human p53 gene by hepatitis B viral X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

p53 regulates mitochondrial respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735410380613

21 January 2018

Identifiers

DOI

10.1177/1534735410380613

1 reference

release_bxjthj4ugrdojljnpog4jdjydy

3 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bxjthj4ugrdojljnpog4jdjydy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference